Volume 14, Issue 2 (March & April 2023)                   BCN 2023, 14(2): 311-316 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Peño L I C, De Miguel C L D S, de Torres L, Ortiz M E, Moreno M J G, Rodeño B O, et al . Brain Atrophy and Physical and Cognitive Disability in Multiple Sclerosis. BCN 2023; 14 (2) :311-316
URL: http://bcn.iums.ac.ir/article-1-1522-en.html
1- Department of Neurology, Torrejón University Hospital, Madrid, Spain.
2- Department of Radiology, Torrejón University Hospital, Madrid, Spain.
Introduction: Brain atrophy is associated with physical disability in multiple sclerosis (MS), but there is a great variability between different studies and methodologies, and its use is still limited to research projects. We aimed to analyze the relationship between several volumetric measurements and physical disability and cognitive functioning in MS patients in a clinical practice setting. 
Methods: This is a cross-sectional study. A total of 41 patients (31 relapsing-remitting MS, 6 secondary-progressive MS, and 4 primary-progressive MS) were included. Whole brain volume (WBV), gray matter volume (GMV), and T2 lesion load (T2L) were obtained using Icometrix® software. Physical disability was measured with the Expanded Disability Status Scale (EDSS), and cognitive status was evaluated with the brief repeatable battery of neuropsychological tests (BRB-N). The relationship between brain volumes and EDSS was analyzed through linear multivariate regression. The association between volumetry measurements and the number of affected cognitive domains was studied with negative binomial regression.
Results: GMV was associated with age (b=-1.7, p=0.014) and with EDSS (b=-7.55, p=0.013). T2L was associated with EDSS (b=2.29, p=0.032). The number of affected cognitive domains was associated with clinical phenotype, worse in primary progressive MS (PPMS). There was not correlations between cognitive impairment and cerebral volumes.
Conclusion: Brain atrophy measurement is feasible in clinical practice setting, and it is helpful in monitoring the EDSS progression. Primary progressive phenotype is associated with greater risk of cognitive dysfunction.
Type of Study: Original | Subject: Clinical Neuroscience
Received: 2019/06/4 | Accepted: 2020/11/21 | Published: 2023/03/28

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb